none the less, they are putting some skin in the game when the world is saying oil is dead for a couple of years. They can see the future of corr from "under the cover" so to say.
Allow me to say this, I have minimal invested here 2K shares, I am enjoying the conversation.
Not very up to date , wonder when he wrote it.
Safety, safety safety is of primary importance in these trials, this latest announcement adds credibility to Neuvax's profile. The writing is on the wall, the clock is ticking, the countdown has begun.
Just how much ($$) will galena be able to charge for the full set of treatment. I have read initially that $1000.00 per injection (I believe it was article from 2012) was in the cards. Also, somebody posted $40,000 per injection. Who really knows? Could this have a bearing on current expectations?
picking up a few more pet (shares)rocks along the way, if you have time to wait those pet rocks multiply (in value).
TEVA Pharmaceuticals is a worldwide pharmaceutical company. They will be responsible for the distribution of the vaccine in Israel and the rest of the world. Galena will receive a royalty on all sales of the drug, once it is approved for use. Phase III trials will start soon in Israel. Currently, there are open trials in the United States and Canada.
Are the #'s already agreed upon? Does management know the potential?